Anti-Inflammatory FAQ — Common Questions About Pain and Inflammation Treatment

Anti-inflammatory medications are drugs that reduce inflammation - the body natural response to injury, infection, or harmful stimuli. While acute inflammation is beneficial and self-limiting, chronic inflammation causes tissue damage and underlies many serious diseases. Anti-inflammatories work through various mechanisms targeting different steps in the inflammatory cascade.

Major categories of anti-inflammatory medications:

• NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) - block COX enzymes reducing prostaglandins (ibuprofen, naproxen, aspirin)
• Corticosteroids - broad-spectrum through multiple pathways (prednisone, dexamethasone)
• 5-Aminosalicylates - local action in gut (mesalamine, sulfasalazine)
• DMARDs - modify disease process (methotrexate, sulfasalazine)
• Biologics - target specific immune molecules (TNF inhibitors, IL-6 inhibitors)
• JAK inhibitors - block intracellular signaling
• Antifibrotics - reduce tissue scarring (pirfenidone)
• Immunosuppressants - broad immune suppression

How they work at cellular level:

Available specialized anti-inflammatories on rxshop.md:

• Asacol (Mesalamine) - for ulcerative colitis
• Azulfidine (Sulfasalazine) - for IBD and rheumatoid arthritis
• Pirfenex (Pirfenidone) - for idiopathic pulmonary fibrosis

Anti-inflammatory medications should be used when inflammation causes symptoms, tissue damage, or disease progression that outweighs medication risks. Different anti-inflammatories are appropriate for different situations.

Common appropriate uses:

NSAIDs (short-term):

• Acute pain (injury, dental work, surgery recovery)
• Fever reduction
• Menstrual cramps
• Headaches and migraines
• Muscle strains
• Occasional arthritis flares
• Acute gout attacks

NSAIDs (chronic - carefully considered):

• Osteoarthritis with significant symptoms
• Rheumatoid arthritis (as adjunct)
• Ankylosing spondylitis
• Chronic musculoskeletal pain

Corticosteroids:

• Severe asthma or COPD exacerbations
• Autoimmune disease flares
• Severe allergic reactions
• Inflammatory bowel disease flares
• Certain cancers as adjunctive treatment
• Transplant rejection prevention
• Adrenal insufficiency replacement

5-Aminosalicylates (specialized IBD treatment):

• Mild to moderate Asacol (Mesalamine) for ulcerative colitis
• Maintenance of remission in ulcerative colitis
• Azulfidine (Sulfasalazine) for IBD and rheumatoid arthritis

Antifibrotics like Pirfenidone:

• Pirfenex (Pirfenidone) for idiopathic pulmonary fibrosis
• Slows disease progression
• Reduces acute exacerbations

When NOT to use anti-inflammatories:

• Mild symptoms that will resolve on their own
• Simple viral infections (unless specific inflammation problem)
• Conditions requiring different treatment
• When contraindications present
• Without proper diagnosis for chronic use

Considerations before starting:

• Correct diagnosis of underlying condition
• Balance benefits vs side effect risks
• Duration of expected treatment
• Interactions with other medications
• Individual patient factors (age, comorbidities)
• Cost and access considerations
• Monitoring requirements

Steroidal anti-inflammatories (corticosteroids) and nonsteroidal anti-inflammatories (NSAIDs) are two fundamentally different classes with distinct mechanisms, potency, uses, and side effect profiles.

Steroidal Anti-Inflammatories (Corticosteroids):

Mechanism: Bind to intracellular receptors regulating gene expression. Effects include:

• Reduce production of many inflammatory mediators
• Suppress immune cell function
• Decrease cytokine production
• Stabilize cell membranes
• Reduce blood vessel permeability
• Broader anti-inflammatory effects than NSAIDs

Examples:

• Prednisone and prednisolone
• Methylprednisolone
• Dexamethasone
• Hydrocortisone
• Budesonide
• Inhaled corticosteroids (fluticasone, budesonide)
• Topical corticosteroids

Uses:

• Severe asthma or COPD exacerbations
• Autoimmune disease flares
• Severe allergic reactions
• IBD flares (systemic or budesonide)
• Skin conditions
• Certain cancers
• Adrenal insufficiency
• Transplant rejection prevention

Side effects (short-term less than 2 weeks):

• Insomnia, mood changes
• Increased appetite
• Fluid retention
• Blood sugar elevation
• Stomach irritation

Side effects (long-term serious):

• Osteoporosis and fractures
• Diabetes mellitus
• Weight gain, Cushingoid appearance
• Cataracts and glaucoma
• Increased infection susceptibility
• Adrenal suppression
• Skin thinning and easy bruising
• Muscle weakness
• Growth suppression in children

Nonsteroidal Anti-Inflammatories (NSAIDs):

Mechanism: Block cyclooxygenase (COX) enzymes reducing prostaglandin production. Effects:

• Reduce pain
• Reduce inflammation
• Reduce fever
• Anti-platelet effects (aspirin)

Examples:

• Ibuprofen
• Naproxen
• Aspirin
• Diclofenac
• Meloxicam
• Celecoxib (COX-2 selective)
• Indomethacin
• Ketorolac

Uses:

• Pain relief
• Fever reduction
• Arthritis symptoms
• Menstrual cramps
• Headaches
• Injury inflammation

Side effects:

• Gastrointestinal ulcers and bleeding
• Kidney damage
• Cardiovascular events (heart attack, stroke)
• Blood pressure elevation
• Fluid retention
• Allergic reactions
• Reyes syndrome (aspirin in children)

Key differences summary:

• Potency: Corticosteroids much more potent
• Scope: Corticosteroids broader anti-inflammatory effects
• Availability: NSAIDs often OTC; corticosteroids usually prescription
• Duration: NSAIDs used short-term or intermittent; corticosteroids for defined courses
• Side effects: Different profiles requiring different monitoring
• Cost: Both generally inexpensive as generics
• Withdrawal: Corticosteroids need gradual tapering after long use; NSAIDs can be stopped

Combined use considerations:

• Sometimes used together for severe conditions
• Additive risk of stomach problems
• Additive risk of fluid retention
• Consider stomach protection

Inflammatory Bowel Disease (IBD) is an umbrella term for chronic inflammatory conditions of the digestive tract. The two main types are Ulcerative Colitis and Crohn Disease. Both involve immune system-mediated chronic inflammation but differ in location, pattern, and complications.

Ulcerative Colitis characteristics:

• Location: Colon and rectum only
• Pattern: Continuous from rectum extending upward
• Depth: Superficial (mucosal) inflammation only
• Symptoms: Bloody diarrhea, urgency, tenesmus (feeling of incomplete evacuation)
• Complications: Toxic megacolon, colon cancer risk, primary sclerosing cholangitis
• Surgery: Colectomy (colon removal) can be curative

Crohn Disease characteristics:

• Location: Anywhere from mouth to anus (most commonly ileum)
• Pattern: Patchy "skip lesions" with normal tissue between
• Depth: Transmural (full thickness of bowel wall)
• Symptoms: Diarrhea, abdominal pain, weight loss, fatigue
• Complications: Strictures, fistulas, abscesses, malabsorption
• Surgery: Cannot cure, may need repeatedly for complications

IBD statistics:

• Affects approximately 3 million people in United States
• Approximately 0.3-0.5 percent of population in developed nations
• Peak diagnosis ages 15-30
• Second peak diagnosis ages 60-80
• Family history increases risk 5-10 fold
• Higher prevalence in Ashkenazi Jewish population
• Increasing globally including previously low-prevalence regions

Causes of IBD:

Exact cause unknown but likely combination of:

• Genetic susceptibility (multiple genes)
• Abnormal immune response to gut bacteria
• Environmental triggers (diet, smoking, antibiotics, medications)
• Urbanization and industrialization
• Vitamin D deficiency
• Stress can trigger flares (not cause disease)

Symptoms during flares:

• Persistent diarrhea (sometimes bloody)
• Abdominal pain and cramping
• Urgent need to defecate
• Feeling of incomplete evacuation
• Weight loss and reduced appetite
• Fatigue and weakness
• Fever
• Blood in stool
• Extra-intestinal symptoms (joint pain, skin rashes, eye inflammation)

Diagnosis:

• Colonoscopy with biopsies
• Blood tests (inflammation markers, anemia, nutritional deficits)
• Stool tests (rule out infection, calprotectin marker)
• Imaging (CT, MRI for Crohn disease evaluation)
• Sometimes small bowel imaging

Treatment approach:

Treatment goals include inducing remission during flares, maintaining remission, healing intestinal tissue, and preventing complications:

• Mild to moderate: Asacol (Mesalamine) or Azulfidine (Sulfasalazine)
• Moderate to severe: Corticosteroids for flares, immunomodulators for maintenance
• Severe or refractory: Biologics (TNF inhibitors, integrin inhibitors, IL-23 inhibitors)
• Complications: Surgery may be needed

Living with IBD:

• Chronic disease requiring long-term treatment
• Alternating periods of active disease and remission
• Individual disease pattern varies
• Modern treatment allows most patients relatively normal lives
• Ongoing monitoring essential
• Nutritional support often needed
• Regular follow-up with gastroenterologist

Asacol (Mesalamine) is the most commonly prescribed 5-aminosalicylate (5-ASA) compound for ulcerative colitis worldwide. It provides targeted anti-inflammatory action directly in the intestinal tract with minimal systemic absorption.

How mesalamine works:

Delivery mechanisms in different formulations:

Different mesalamine products use different technologies to deliver active drug to specific bowel segments:

• Asacol - delayed-release coating dissolves at higher pH releasing in terminal ileum and colon
• Extended-release capsules - throughout small and large intestine
• Rectal suppositories - proctitis (rectal inflammation)
• Rectal enemas - left-sided colitis
• Extended-release granules - colon-targeted

Uses of mesalamine:

• Mild to moderate ulcerative colitis - induce remission
• Maintenance therapy - keep ulcerative colitis in remission
• Some Crohn disease - especially colonic involvement
• Left-sided ulcerative colitis - oral plus rectal often
• Proctitis - inflammation of rectum only
• Reducing colon cancer risk in long-term ulcerative colitis

Expected benefits:

• Reduced inflammation of intestinal lining
• Decreased diarrhea and bleeding
• Reduced urgency and tenesmus
• Endoscopic healing over time
• Prevention of relapses
• Possibly reduced colon cancer risk with long-term use
• Improved quality of life

Typical dosing:

• Active disease: 2.4-4.8 grams daily
• Maintenance: 1.5-2.4 grams daily
• Multiple daily doses or once-daily formulations available
• Take with adequate fluid
• Continue full course as prescribed

Advantages of mesalamine:

• Excellent safety profile
• Suitable for long-term use
• Minimal systemic effects
• Effective for maintaining remission
• Safe during pregnancy
• Compatible with breastfeeding
• Can be used in children
• Steroid-sparing effect

Common side effects:

• Headache (most common)
• Nausea and abdominal pain
• Diarrhea
• Gas and bloating
• Rash
• Fatigue
• Generally well tolerated

Serious but rare side effects:

• Kidney problems (rare interstitial nephritis)
• Pancreatitis
• Blood dyscrasias
• Liver function abnormalities
• Paradoxical worsening of colitis
• Severe allergic reactions

Monitoring during treatment:

• Baseline kidney function tests
• Periodic renal function monitoring
• Complete blood count
• Symptom assessment at follow-ups
• Colonoscopy periodically for mucosal healing

Practical tips:

• Take with adequate fluid
• May take weeks to reach full effect
• Continue during remission for maintenance
• Do not stop suddenly without medical guidance
• Report any concerning symptoms
• Do not crush or split delayed-release tablets
• Follow prescribed schedule consistently

Azulfidine (Sulfasalazine) is a unique medication with dual therapeutic uses: treatment of inflammatory bowel disease and rheumatoid arthritis. It combines two active components - sulfapyridine and 5-aminosalicylic acid - linked by an azo bond that gets broken by colon bacteria.

How sulfasalazine works:

FDA-approved uses:

1. Inflammatory Bowel Disease

• Ulcerative colitis - both active flares and maintenance
• Some cases of Crohn disease with colonic involvement
• Alternative to newer mesalamine formulations
• Cost-effective option

2. Rheumatoid Arthritis

• Disease-modifying antirheumatic drug (DMARD)
• Slows joint damage progression
• Alternative to methotrexate
• Sometimes used in combination with other DMARDs
• Effective for reducing pain, stiffness, and joint damage

3. Juvenile Idiopathic Arthritis

• Alternative treatment in children with certain forms
• Well-established pediatric use

4. Ankylosing Spondylitis

• Effective for peripheral joint involvement
• Less effective for spinal disease

Typical dosing:

For ulcerative colitis:

• Active disease: 3-4 grams daily in divided doses
• Maintenance: 2 grams daily
• Take with food to reduce GI upset

For rheumatoid arthritis:

• Start with 500 mg twice daily
• Gradually increase to 2-3 grams daily
• Full effect takes 6-12 weeks
• Take with food

Advantages of sulfasalazine:

• Dual use for gastroenterology and rheumatology
• Long history of use with established safety profile
• Cost-effective
• Available as generic
• Effective for many patients
• Well-studied
• Can be used during pregnancy

Common side effects (30-40 percent of patients):

• Nausea and vomiting
• Headache
• Loss of appetite
• Fatigue
• Rash
• Fever
• Diarrhea
• Orange discoloration of urine and body fluids (harmless)

Serious but less common side effects:

• Blood disorders (leukopenia, agranulocytosis, hemolytic anemia)
• Liver function abnormalities
• Hypersensitivity reactions
• Steven-Johnson syndrome (rare)
• Interstitial nephritis
• Peripheral neuropathy
• Depression
• Photosensitivity

Specific considerations:

Male fertility:

• Can cause reversible reduction in sperm count
• Effects on sperm quality and motility
• Recovers within few months of stopping
• Consider if trying to conceive

Folate deficiency:

• Sulfasalazine interferes with folate absorption
• Folate supplementation typically recommended
• Especially important during pregnancy
• Monitor for signs of deficiency

Sulfa allergy:

• Contraindicated if sulfa drug allergy
• Contains sulfapyridine component
• Alternative: mesalamine (no sulfa component)

Monitoring requirements:

• Baseline CBC, liver function, kidney function
• Regular blood monitoring during treatment
• Symptom review at follow-up visits
• Watch for signs of blood disorders
• Sun protection due to photosensitivity

Comparison with mesalamine:

• Sulfasalazine advantages: dual use (IBD + RA), less expensive
• Mesalamine advantages: fewer side effects, no sulfa component
• Choice depends on specific condition and patient factors
• Both effective for ulcerative colitis
• Only sulfasalazine used for rheumatoid arthritis

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive lung disease of unknown cause characterized by scarring (fibrosis) of lung tissue. This scarring makes lungs stiff, reducing oxygen exchange and causing progressive breathing difficulty. Without treatment, IPF typically has poor prognosis with median survival of only 3-5 years from diagnosis.

Understanding IPF:

• Idiopathic - cause unknown (though risk factors identified)
• Pulmonary - affects lungs
• Fibrosis - progressive scarring of lung tissue
• Chronic and progressive
• Different from other lung diseases (COPD, asthma, sarcoidosis)
• Rare disease - affects approximately 3 million people globally

Risk factors for IPF:

• Age - typically diagnosed 50-70 years old
• Male sex - more common in men
• Smoking - major risk factor
• Occupational exposures - wood dust, metal dust, farming
• Viral infections - possible role for certain viruses
• Genetic predisposition - familial forms exist
• Gastroesophageal reflux - potential contributor
• Environmental pollutants

IPF symptoms:

• Progressive shortness of breath - initially with exertion, later at rest
• Dry chronic cough - non-productive, persistent
• Fatigue
• Unintentional weight loss
• Clubbing of fingers - late stage
• Reduced exercise tolerance
• Rapid breathing
• Muscle and joint aches

How Pirfenidone works:

Pirfenex (Pirfenidone) is one of only two FDA-approved medications for IPF (the other being nintedanib). It works through multiple mechanisms:

• Antifibrotic action - inhibits fibroblast proliferation and collagen production
• Blocks TGF-beta pathway - key mediator of fibrosis
• Anti-inflammatory effects - reduces various inflammatory cytokines
• Antioxidant properties - reduces oxidative stress
• Modulates cellular signaling involved in scarring

Clinical benefits demonstrated:

• Slows decline in forced vital capacity (FVC)
• Reduces risk of acute exacerbations
• Extends progression-free survival
• May reduce mortality
• Improves quality of life measures
• Delays need for lung transplantation

Typical dosing (must be titrated gradually):

• Week 1: 267 mg three times daily (one 267 mg tablet per dose)
• Week 2: 534 mg three times daily (two tablets per dose)
• Week 3 onwards: 801 mg three times daily (three 267 mg tablets or one 801 mg tablet per dose)
• Standard 200 mg tablets in Pirfenex - adjust dosing accordingly
• Take with food - substantially reduces gastrointestinal side effects
• Titration reduces side effects and improves tolerability

Important side effects:

• Photosensitivity - severe sun sensitivity reactions requiring rigorous sun protection
• Gastrointestinal - nausea (36 percent), vomiting, dyspepsia, diarrhea
• Rash
• Fatigue
• Headache
• Anorexia and weight loss
• Liver enzyme elevation
• Dizziness

Critical sun protection:

• Avoid or minimize sun exposure
• Use broad-spectrum sunscreen SPF 50+
• Wear protective clothing
• Hat with wide brim
• Sunglasses
• Cover exposed skin
• Sun protection essential even on cloudy days

Monitoring requirements:

• Baseline liver function tests
• Monthly liver function tests for first 6 months
• Every 3 months thereafter
• Watch for signs of liver problems
• Report severe skin reactions immediately
• Regular pulmonary function tests
• Assess treatment response

Contraindications:

• Severe hepatic impairment
• Known hypersensitivity to pirfenidone
• Use during pregnancy avoided when possible

Drug interactions:

• Ciprofloxacin - reduces pirfenidone metabolism (dose reduction needed)
• Strong CYP1A2 inhibitors - avoid combination
• Cigarette smoking - reduces effectiveness (yet another reason to quit)
• Fluvoxamine - contraindicated

Comprehensive IPF care:

• Antifibrotic medication (pirfenidone or nintedanib)
• Smoking cessation absolutely essential
• Pulmonary rehabilitation
• Oxygen therapy as needed
• Vaccinations (flu, pneumonia)
• Treatment of comorbidities (GERD, sleep apnea)
• Lung transplantation for selected patients
• Palliative care integration
• Support groups and psychosocial support

Realistic expectations:

• Pirfenidone does NOT reverse existing scarring
• Does NOT cure IPF
• Slows progression but does not stop completely
• Some patients respond better than others
• Requires long-term commitment
• Side effects can be significant
• Better outcomes with earlier initiation

Long-term anti-inflammatory use carries significant risks depending on which class of medication is used. Understanding these risks helps balance benefits against harms for chronic conditions requiring extended treatment.

NSAID long-term risks:

Gastrointestinal complications:

• Peptic ulcers - occur in 15-30 percent of chronic users
• GI bleeding - can be silent and severe
• Perforation - medical emergency
• Small bowel injury - increasingly recognized
• NSAID-induced dyspepsia

Cardiovascular risks:

• Increased heart attack risk (5-30 percent higher)
• Increased stroke risk
• Higher risk with COX-2 selective agents (celecoxib somewhat lower)
• Blood pressure elevation
• Heart failure exacerbation
• Higher risk in existing cardiovascular disease

Kidney complications:

• Acute kidney injury
• Chronic kidney disease progression
• Fluid retention
• Electrolyte abnormalities
• Higher risk in elderly and those with existing kidney problems

Corticosteroid long-term risks:

Bone health:

• Osteoporosis - most common serious complication
• Increased fracture risk (spine, hip)
• Avascular necrosis of bones
• Delayed bone growth in children

Metabolic effects:

• Diabetes mellitus - elevated blood sugar
• Weight gain, particularly truncal
• Cushingoid appearance (moon face, buffalo hump)
• Lipid abnormalities
• Increased appetite

Endocrine effects:

• Adrenal suppression - cannot stop abruptly
• Growth suppression in children
• Menstrual irregularities
• Sexual dysfunction

Infection risk:

• Increased susceptibility to bacterial infections
• Increased fungal infection risk (yeast, thrush)
• Reactivation of tuberculosis
• More severe viral infections

Eye complications:

• Cataracts
• Glaucoma
• Central serous chorioretinopathy

Skin problems:

• Skin thinning
• Easy bruising
• Delayed wound healing
• Stretch marks
• Poor skin quality

Psychiatric effects:

• Mood changes (euphoria, depression, mania)
• Insomnia
• Anxiety
• Rarely psychosis

5-Aminosalicylates (Asacol, Azulfidine) long-term:

Generally excellent long-term safety, but consider:

• Kidney function monitoring (rare interstitial nephritis)
• Blood monitoring (rare dyscrasias)
• Sulfasalazine - folate deficiency
• Sulfasalazine - male fertility effects (reversible)
• Overall well-tolerated for years to decades

DMARDs long-term:

Methotrexate:

• Liver toxicity requires regular monitoring
• Bone marrow suppression
• Interstitial pneumonitis
• Increased infection risk

Biologics long-term:

• Infection risk (bacterial, viral, fungal)
• Tuberculosis reactivation
• Rare demyelinating disorders
• Rare cancer risk (lymphoma, skin)
• Injection site reactions
• Antibody development against drug

Pirfenidone long-term:

• Severe photosensitivity - permanent risk
• Liver function monitoring
• Gastrointestinal effects may persist
• Weight loss

Strategies for safe long-term use:

1. Regular monitoring

• Blood work at prescribed intervals
• Bone density scans on chronic steroids
• Eye exams on chronic steroids
• Symptom assessment at each visit
• Screening for complications

2. Preventive measures

• Calcium and vitamin D for steroid users
• Bisphosphonates for osteoporosis prevention
• Proton pump inhibitors for GI protection with NSAIDs
• Vaccinations for immunosuppressed patients
• Sun protection for photosensitive drugs

3. Use lowest effective dose

• Titrate down whenever possible
• Periodic reassessment of need
• Alternate day dosing for some steroids
• Topical or local delivery when possible
• Steroid-sparing agents when appropriate

4. Address risk factors

• Weight management
• Exercise for bone and cardiovascular health
• Smoking cessation
• Alcohol moderation
• Diabetes screening
• Cardiovascular risk assessment

5. Consider alternatives

• Non-pharmacological treatments
• Different drug classes
• Combination therapy with lower doses
• Surgery when appropriate

When to reconsider treatment:

• Serious side effects develop
• Complications outweigh benefits
• Better alternatives available
• Disease no longer active
• Patient preference changes

Never stop abruptly:

• Corticosteroids need gradual tapering
• Some biologics require careful discontinuation
• Sudden stopping can trigger disease flares
• Always discuss with healthcare provider

Balance perspective:

• Untreated inflammation causes ongoing damage
• Long-term risks must be weighed against disease progression risks
• Modern monitoring makes safe long-term use possible
• Many patients maintain good quality of life on chronic therapy
• Regular healthcare provider communication essential

Side effects of anti-inflammatory medications vary substantially by drug class. Understanding potential effects helps recognize concerning symptoms and manage tolerable ones.

NSAID common side effects:

Gastrointestinal (most common):

• Stomach upset, nausea
• Heartburn and indigestion
• Abdominal pain
• Ulcers (up to 30 percent chronic users)
• GI bleeding (sometimes without warning)
• Diarrhea or constipation

Cardiovascular:

• Elevated blood pressure
• Fluid retention and edema
• Increased risk of heart attack and stroke (chronic use)
• Worsening heart failure

Kidney:

• Reduced kidney function
• Acute kidney injury (particularly elderly, dehydrated)
• Electrolyte abnormalities

Other:

• Headache
• Dizziness
• Skin rash
• Allergic reactions
• Photosensitivity (some NSAIDs)

Corticosteroid side effects:

Short-term (less than 2 weeks):

• Insomnia and sleep disturbance
• Mood changes (euphoria, irritability)
• Increased appetite
• Fluid retention
• Elevated blood sugar
• Stomach irritation
• Increased sweating

Long-term (more than 2-3 weeks):

• Weight gain and Cushingoid appearance
• Osteoporosis and fractures
• Diabetes development
• Cataracts and glaucoma
• Increased infection susceptibility
• Skin thinning and easy bruising
• Muscle weakness
• Adrenal suppression
• Depression or psychiatric changes
• Growth suppression in children

Mesalamine (Asacol) side effects:

• Common (usually mild):
• Headache
• Nausea and abdominal pain
• Diarrhea
• Gas and bloating
• Rash
• Fatigue

Serious but rare mesalamine effects:

• Kidney problems (interstitial nephritis)
• Pancreatitis
• Blood disorders
• Liver enzyme elevation
• Paradoxical worsening of colitis
• Severe allergic reactions

Sulfasalazine (Azulfidine) side effects:

• Common (30-40 percent):
• Nausea and vomiting
• Headache
• Loss of appetite
• Fatigue
• Fever
• Orange discoloration of urine/tears (harmless)
• Rash
• Photosensitivity

Serious sulfasalazine effects:

• Blood disorders (agranulocytosis, hemolytic anemia)
• Liver dysfunction
• Severe skin reactions
• Male fertility effects (reversible)
• Folate deficiency
• Peripheral neuropathy

Pirfenidone (Pirfenex) side effects:

• Severe photosensitivity - most distinctive side effect
• Gastrointestinal:
• Nausea (36 percent of patients)
• Vomiting
• Dyspepsia
• Diarrhea
• Loss of appetite
• Other:
• Rash
• Fatigue
• Headache
• Weight loss
• Liver enzyme elevation
• Dizziness

Warning signs requiring immediate medical attention:

Managing common side effects:

Gastrointestinal effects:

• Take with food when appropriate
• Consider H2 blocker or PPI if using NSAIDs long-term
• Stay well hydrated
• Report severe or persistent symptoms

Photosensitivity (pirfenidone, sulfasalazine):

• Rigorous sun protection
• Broad-spectrum sunscreen SPF 50+
• Protective clothing
• Avoid peak sun hours
• Cover exposed skin

Steroid side effects prevention:

• Calcium and vitamin D supplementation
• Weight-bearing exercise for bone health
• Blood sugar monitoring
• Regular eye exams
• Vaccinations current
• Skin care

When to consider medication changes:

• Intolerable side effects
• Serious adverse events
• Failure to control disease
• Better alternatives available
• Patient preference
• Cost concerns

Communication with healthcare providers:

• Report all side effects
• Ask questions about expected effects
• Discuss any concerns
• Do not stop medications without consultation
• Keep updated medication list
• Include OTC drugs and supplements

Anti-inflammatory medication use during pregnancy requires careful consideration of both maternal disease control and fetal safety. Some medications are relatively safe while others must be avoided.

General principles:

• Untreated inflammatory diseases can harm both mother and fetus
• Some medications must be continued for maternal health
• Others should be avoided if possible
• Individual risk-benefit assessment essential
• Coordinate care between specialists and obstetrician
• First trimester particularly vulnerable

Generally considered safe during pregnancy:

Mesalamine (Asacol) - Category B:

• Extensive safety data
• Continued use recommended for IBD control
• Minimal systemic absorption
• Continue during pregnancy in most cases
• Uncontrolled IBD flares more dangerous than medication

Sulfasalazine (Azulfidine) - Category B:

• Considered safe during pregnancy
• Folate supplementation essential (higher dose than usual)
• Continue for IBD or rheumatoid arthritis
• Alternative to more toxic medications
• Monitor for maternal side effects

Prednisone/prednisolone - Category C:

• Can be used when necessary
• Use lowest effective dose
• Watch for gestational diabetes
• Monitor for hypertension
• Watch for fetal growth restriction
• Better for maternal disease control than uncontrolled inflammation

Acetaminophen (not truly anti-inflammatory):

• First choice for pain and fever
• Considered safe throughout pregnancy
• Some recent studies question long-term effects
• Use lowest effective dose

Use with caution during pregnancy:

NSAIDs:

• Generally avoid, especially third trimester
• Third trimester - premature closure of ductus arteriosus, oligohydramnios
• First trimester - possible increased miscarriage risk
• Chronic use associated with pregnancy complications
• Short courses of ibuprofen sometimes used first or second trimester

Aspirin:

• Low-dose (81 mg) actually recommended for some conditions (preeclampsia prevention)
• Higher doses avoided
• Discuss with obstetrician

Biologics:

• Individual assessment for each biologic
• Some (certolizumab) considered safer due to lack of placental transfer
• TNF inhibitors - complex risk-benefit
• Discuss with rheumatologist/gastroenterologist and OB

AVOID during pregnancy:

Methotrexate:

• Absolutely contraindicated - teratogenic and abortifacient
• Stop 3 months before attempting pregnancy
• Both partners should avoid before conception attempts
• Folate supplementation important

Leflunomide:

• Long half-life, contraindicated in pregnancy
• Requires washout procedure before pregnancy
• Both partners considerations

Mycophenolate:

• Teratogenic - contraindicated
• Alternative treatments needed

Pirfenidone (Pirfenex):

• Insufficient safety data
• Avoid unless clearly essential
• Effective contraception during use
• Consider risk-benefit for pregnant IPF patients

Ibuprofen and NSAIDs (third trimester):

• Avoid completely in third trimester
• Premature closure of ductus arteriosus
• Oligohydramnios (low amniotic fluid)
• Prolongation of labor
• Neonatal complications

Specific condition considerations:

IBD during pregnancy:

• Uncontrolled disease more dangerous than medications
• Active disease during conception associated with poor outcomes
• Continue Asacol (Mesalamine) throughout pregnancy
• Continue Azulfidine (Sulfasalazine) with folate supplementation
• Steroids can be used for flares
• Biologics individually assessed
• Get into remission before pregnancy when possible

Rheumatoid arthritis during pregnancy:

• Often improves during pregnancy naturally
• Continue safer medications (sulfasalazine, hydroxychloroquine)
• Corticosteroids for flares
• Watch for postpartum flare

IPF during pregnancy:

• Rare in women of reproductive age
• Pirfenidone use requires careful discussion
• Consider risk of untreated disease progression
• Specialist consultation essential

Breastfeeding considerations:

Compatible with breastfeeding:

• Mesalamine - minimal transfer to milk
• Sulfasalazine - generally compatible
• Prednisone at low to moderate doses
• Ibuprofen - preferred NSAID for lactation
• Acetaminophen

Use with caution:

• Aspirin - due to Reyes syndrome concern
• Some biologics

Generally avoid:

• Methotrexate
• Cyclosporine
• Long-acting corticosteroids

Planning pregnancy:

• Discuss with all treating specialists
• Optimize disease control before conception
• Adjust medications appropriately in advance
• Address folate supplementation
• Update vaccinations
• Manage comorbidities

Communication essentials:

• Inform all providers of pregnancy status
• Consult before any medication changes
• Discuss both maternal and fetal risks
• Consider risks of NOT treating
• Do not stop medications without discussion
• Follow-up as recommended

Many anti-inflammatory medications can be used safely in children with appropriate dosing and monitoring, but pediatric use requires special considerations.

NSAIDs in children:

Ibuprofen:

• Approved for children 6 months and older
• Weight-based dosing essential
• Available as liquid, chewable, tablets
• Common uses: fever, pain, juvenile arthritis
• Watch for kidney effects, dehydration

Naproxen:

• Approved for children 2 years and older
• Longer duration than ibuprofen
• Weight-based dosing

Aspirin - AVOID in children:

• Reyes syndrome - rare but potentially fatal condition
• Associated with aspirin use during viral illnesses (chickenpox, flu)
• Not for children under 18 for pain/fever
• Exception: Kawasaki disease under medical supervision

Common pediatric conditions treated with NSAIDs:

• Fever
• Pain from injuries
• Post-surgical pain
• Juvenile idiopathic arthritis
• Menstrual cramps
• Dental pain

Corticosteroids in children:

Used when necessary for specific conditions:

• Severe asthma exacerbations
• Juvenile idiopathic arthritis
• IBD flares
• Nephrotic syndrome
• Severe allergic reactions
• Certain skin conditions

Special pediatric concerns with steroids:

• Growth suppression - major concern with chronic use
• Delayed puberty possible
• Bone development effects
• Cataracts and glaucoma
• Mood and behavior changes
• Infection susceptibility (avoid live vaccines)
• Higher metabolic effects per body weight

Strategies to minimize pediatric steroid effects:

• Use lowest effective dose
• Shortest possible duration
• Consider alternate day dosing
• Use inhaled or topical steroids when possible
• Regular growth monitoring
• Bone density assessments for chronic use
• Calcium and vitamin D supplementation

Mesalamine in children:

• Asacol (Mesalamine) used for pediatric IBD
• Excellent safety profile
• Weight-based dosing
• Multiple formulations available
• Long-term use generally safe
• Alternative to steroids for maintenance

Sulfasalazine in children:

• Azulfidine (Sulfasalazine) for juvenile idiopathic arthritis and IBD
• Well-established pediatric use
• Folate supplementation important
• Monitor for blood disorders
• Check for sulfa allergy
• Photosensitivity precautions

DMARDs in pediatric patients:

Methotrexate:

• Well-established use in juvenile idiopathic arthritis
• Standard treatment for many pediatric rheumatic conditions
• Weekly dosing
• Folate supplementation
• Regular blood monitoring

Biologics in children:

• Increasingly used for severe conditions
• Adalimumab, etanercept for JIA
• Various biologics for pediatric IBD
• Higher rates of certain complications
• Specialist supervision essential

Pirfenidone in children:

• Not established for pediatric use
• IPF is rare in children
• Would require specialist consultation

Practical pediatric administration tips:

1. Accurate dosing

• Always use provided measuring device
• Never use kitchen spoons for liquid medications
• Weight-based dosing more accurate than age
• Adjust as child grows

2. Formulation choice

• Liquid for younger children
• Chewable tablets for school age
• Regular tablets when able to swallow
• Consider taste preferences

3. Safety storage

• Keep out of reach of children
• Use child-resistant caps properly
• Store at appropriate temperature
• Refrigerate liquid antibiotics as directed

4. Compliance strategies

• Establish consistent routine
• Positive reinforcement
• Use flavor enhancers if allowed
• Reward systems for older children
• Explain importance in age-appropriate way

Common pediatric side effects:

• Digestive symptoms most common
• Rash
• Growth effects (steroids)
• Behavioral changes (steroids)
• Watch for allergic reactions

When to seek immediate care:

• Difficulty breathing
• Widespread rash
• Severe vomiting
• Signs of allergic reaction
• Severe abdominal pain
• Any concerning new symptom

Vaccinations during immunosuppressive therapy:

• Avoid live vaccines on high-dose steroids or biologics
• Inactivated vaccines generally safe
• Consult pediatrician before vaccinating
• Maintain current immunizations before starting therapy
• Consider annual flu vaccine

Family and school considerations:

• Communicate with school nurses
• Written care plans for schools
• Emergency contact information
• Educate teachers about condition
• Provide medications for school administration
• Prepare for potential emergencies

Long-term perspective:

• Regular pediatric specialist follow-up
• Growth and development monitoring
• Transition planning for adolescents
• Address psychosocial impacts
• Support groups may help family
• Educational advocacy when needed

Diet and lifestyle factors substantially influence chronic inflammation levels in the body. While not replacements for medications in serious inflammatory conditions, these interventions can meaningfully reduce inflammation, complement medical treatment, and improve overall health.

Anti-inflammatory diet components:

Foods to emphasize:

• Fatty fish - salmon, mackerel, sardines (omega-3 fatty acids)
• Extra virgin olive oil - monounsaturated fats and oleocanthal
• Colorful fruits - berries, cherries, apples, citrus (antioxidants)
• Cruciferous vegetables - broccoli, cauliflower, Brussels sprouts
• Leafy greens - spinach, kale, arugula
• Nuts and seeds - walnuts, almonds, flaxseeds, chia seeds
• Whole grains - oats, quinoa, brown rice
• Legumes - beans, lentils, chickpeas
• Turmeric and ginger - anti-inflammatory spices
• Green tea - polyphenols
• Dark chocolate - antioxidants

Foods to limit or avoid:

• Processed foods - increase inflammation
• Refined sugars - promote inflammation
• Refined carbohydrates - white bread, pastries
• Trans fats - fried foods, some margarines
• Excessive omega-6 vegetable oils - corn, soybean, sunflower
• Processed meats - bacon, sausage, deli meats
• Red meat in excess
• Artificial sweeteners may affect gut inflammation
• Alcohol in excess
• Excessive salt

Specific diets studied for inflammation:

Mediterranean diet:

• Most extensively studied anti-inflammatory eating pattern
• Associated with reduced inflammatory markers
• Reduced cardiovascular disease risk
• May slow cognitive decline
• Sustainable long-term

DASH diet:

• Dietary Approaches to Stop Hypertension
• Emphasizes fruits, vegetables, whole grains
• Low in sodium and saturated fat
• Associated with reduced inflammation

Specific diets for IBD:

• Low-FODMAP diet for IBS symptoms
• Specific Carbohydrate Diet (some evidence)
• Semi-vegetarian diets
• Individualized dietary counseling recommended
• Avoiding trigger foods
• Adequate nutrition especially during flares

Exercise and inflammation:

Regular moderate exercise substantially reduces inflammation:

• Reduces baseline inflammatory markers
• Improves insulin sensitivity
• Reduces visceral fat (major inflammation source)
• Enhances immune function
• Improves cardiovascular health
• Better mood and stress management
• Better sleep quality

Recommended exercise:

• 150 minutes moderate aerobic activity weekly
• 2 sessions resistance training weekly
• Flexibility and balance activities
• Reduce sedentary time
• Start slowly and progress gradually
• Choose enjoyable activities for consistency

Weight management:

• Excess body fat, especially visceral fat, produces inflammatory cytokines
• Weight loss substantially reduces inflammation
• Even modest weight loss (5-10 percent) helps
• Focus on sustainable changes
• Combine diet and exercise

Sleep quality:

Poor sleep increases inflammation:

• Aim for 7-9 hours nightly
• Consistent sleep schedule
• Address sleep apnea if present
• Optimize sleep environment
• Manage stress affecting sleep
• Limit screens before bed

Stress management:

Chronic stress promotes inflammation:

• Cortisol effects on immune system
• Behavioral effects on health
• Increased inflammatory cytokines

Evidence-based stress reduction:

• Meditation and mindfulness
• Yoga and tai chi
• Deep breathing exercises
• Cognitive behavioral therapy
• Social connections
• Time in nature
• Regular exercise
• Adequate sleep

Smoking cessation:

Smoking causes and worsens inflammation:

• Increases inflammatory markers
• Damages blood vessels
• Worsens autoimmune diseases
• Reduces treatment effectiveness
• Particular concern for IPF, rheumatoid arthritis

Benefits of quitting:

• Rapid reduction in inflammation
• Better response to treatments
• Reduced disease progression
• Extended life expectancy
• Better lung function

Alcohol moderation:

• Excess alcohol promotes inflammation
• Damages liver
• Interferes with sleep
• Adds calories
• Interacts with medications

Guidelines:

• Women: up to 1 drink daily
• Men: up to 2 drinks daily
• Consider complete abstinence
• Some evidence red wine may have benefits in moderation

Gut health optimization:

Gut microbiome influences systemic inflammation:

• Diverse, plant-based diet supports healthy microbiome
• Fermented foods (yogurt, kefir, sauerkraut)
• Prebiotic fibers (bananas, onions, garlic, whole grains)
• Limit unnecessary antibiotics
• Probiotics may help specific conditions

Supplements with potential benefits (discuss with doctor):

• Fish oil (omega-3) - most evidence-based
• Vitamin D - if deficient
• Curcumin (turmeric extract) - some evidence
• Ginger extract
• Bromelain
• Probiotics for specific conditions

Environmental factors:

• Reduce toxin exposure when possible
• Air quality considerations
• Water quality
• Avoid known allergens
• Consider indoor air purification

Social connections:

Social isolation increases inflammation:

• Maintain relationships
• Community involvement
• Volunteer activities
• Support groups
• Family time

Realistic expectations:

• Lifestyle changes complement, do not replace, medical treatment for serious inflammation
• Effects accumulate over time
• Combined approach most effective
• Individual variation in response
• Consult healthcare providers for personalized advice
• Chronic diseases require ongoing management

Bottom line: Diet and lifestyle profoundly affect inflammation levels. Combined with appropriate medications for serious conditions, they optimize outcomes and improve quality of life. Even small consistent changes accumulate meaningful benefits over time.

Anti-inflammatory medications have numerous significant drug interactions. Understanding these interactions helps prevent serious complications and treatment failures.

NSAID drug interactions:

Serious interactions (avoid or careful monitoring):

• Warfarin (Coumadin) - substantially increased bleeding risk
• Direct oral anticoagulants (apixaban, rivaroxaban) - bleeding risk
• Antiplatelet agents (aspirin, clopidogrel) - bleeding risk
• Lithium - toxic accumulation
• Methotrexate - decreased clearance, toxicity risk
• ACE inhibitors and ARBs - reduced blood pressure effect, kidney injury
• Diuretics - reduced effectiveness
• Cyclosporine - increased nephrotoxicity
• Corticosteroids - additive GI ulcer risk

Moderate NSAID interactions:

• SSRIs - increased bleeding risk
• Alcohol - increased GI bleeding
• Herbal supplements - ginkgo, ginger, garlic (bleeding)

Corticosteroid drug interactions:

Serious corticosteroid interactions:

• Live vaccines - avoid during immunosuppression
• Anticoagulants - increased bleeding risk with high-dose steroids
• NSAIDs - additive GI ulcer risk
• Diabetes medications - reduced effectiveness (steroids raise blood sugar)
• Certain antibiotics (rifampin) - reduce steroid effectiveness
• Antifungals (ketoconazole, itraconazole) - increased steroid levels
• Grapefruit juice - increased steroid levels
• Certain HIV medications - complex interactions

Mesalamine (Asacol) interactions:

• Generally fewer interactions
• Azathioprine and 6-mercaptopurine - increased bone marrow toxicity
• Warfarin - possible increased effect
• NSAIDs - additive kidney effects
• Cyclosporine - possible increased nephrotoxicity
• Metronidazole - possible interaction

Sulfasalazine (Azulfidine) interactions:

• Warfarin - increased bleeding risk
• Methotrexate - increased toxicity
• Azathioprine - additive bone marrow suppression
• Digoxin - reduced absorption
• Folate - reduced absorption (supplementation needed)
• Iron - reduced absorption
• Cholestyramine - reduced sulfasalazine absorption

Pirfenidone (Pirfenex) interactions:

• Ciprofloxacin - reduces pirfenidone metabolism (dose reduction)
• Fluvoxamine - CONTRAINDICATED (increases levels dangerously)
• Strong CYP1A2 inhibitors - avoid
• Smoking - reduces pirfenidone levels (yet another quit smoking reason)
• Some antidepressants - interactions possible

DMARD interactions:

Methotrexate:

• NSAIDs - reduced clearance
• Trimethoprim-sulfamethoxazole - increased toxicity
• Penicillins - increased levels
• Alcohol - liver toxicity

Biologics interactions:

• Live vaccines contraindicated
• Other immunosuppressants - additive infection risk
• Some combinations increase infection risk substantially

Preventing interaction problems:

Complete medication review:

• List ALL medications including OTC
• Include vitamins and supplements
• Include herbal products
• Recreational drug use if applicable
• Alcohol consumption
• Recent medication changes

Single pharmacy strategy:

• Fill all prescriptions at same pharmacy when possible
• Allows automatic interaction checking
• Consistent medication reconciliation

Provider communication:

• Inform all providers of all medications
• Update lists at every visit
• Ask about specific new medications
• Report any concerning symptoms

Understand your medications:

• Know major interactions to avoid
• Read patient information
• Ask pharmacist questions
• Use reliable drug interaction resources

Warning signs of interactions:

• Unusual bleeding or bruising
• New or worsening side effects
• Sudden change in disease control
• Signs of medication toxicity
• New symptoms after adding medication

Special situations:

Elderly patients:

• Higher interaction risk (polypharmacy)
• Reduced kidney and liver function
• More sensitive to effects
• Regular medication review essential
• Consider deprescribing when appropriate

Multiple chronic conditions:

• Coordinated care important
• Care manager can help
• Regular medication reconciliation

Common OTC medication concerns:

• NSAIDs (many products contain them)
• Aspirin (in various formulations)
• Antacids (may affect absorption)
• Cold medications (may contain NSAIDs, decongestants)
• Sleep aids (interactions with other CNS medications)

Supplements to be aware of:

• Fish oil - bleeding risk with anticoagulants
• Ginkgo - bleeding risk
• Ginger - bleeding risk
• Garlic - bleeding risk
• St. Johns Wort - many drug interactions
• Vitamin K - warfarin interaction
• Ginseng - various interactions

When to worry about interactions:

• Starting new medication
• Stopping medication
• Dose changes
• New symptoms
• Changes in disease control
• Laboratory abnormalities

Bottom line: Anti-inflammatory medications have complex interaction potential. Maintain updated medication lists, use single pharmacy when possible, communicate with all providers, ask pharmacist questions, and report concerning symptoms promptly. Regular medication reviews prevent problems and optimize treatment.